CNBC's Jim Cramer on Thursday recommended investors take a look at buying stock in diagnostic companies as the coronavirus pandemic rages on.
"That's huge, although we need even more [testing] given these hideous case numbers," said Cramer, who noted a "major bottleneck" in processing tests.
XpresCheck DougSatzman
It's just hilarious. The pumping is unabashed.
If Joe wins the narrative changes. Covid will be non-existent.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite: